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Study highlights 
What is current knowledge 
 Liver disease is the only major cause of mortality that is rising in England. 
 There is no routine registration of the occurrence of newly diagnosed cases of 
cirrhosis in the UK. 
What is new here 
 The occurrence of cirrhosis increased by 51% during 1998 to 2009 in England. 
 Incidence of cirrhosis increased for all aetiologies and for both men and women. 
 Incidence rates of cirrhosis increased more than that of the top four cancers in the 
UK. 
 We estimate approximately 17000 newly diagnosed people with cirrhosis in 2009 in 
the UK, more than that of the fifth most common cancer. 
 Strategies to monitor and reduce the incidence of cirrhosis are urgently needed. 
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ABSTRACT 
Background There is no routine registration of the occurrence of newly diagnosed cases of 
cirrhosis in the UK. This study seeks to determine precise estimates and trends of the 
incidence of cirrhosis in England, and directly compare these figures with those for the 
twenty most commonly diagnosed cancers in the UK. 
Design: We used the Clinical Practice Research Datalink and linked English Hospital 
Episode Statistics to perform a population-based cohort study. Adult incident cases with a 
diagnosis of cirrhosis between January 1998 and December 2009 were identified. We 
described trends in incidence by sex and aetiology. We performed a direct standardisation to 
estimate the number of people being newly diagnosed with cirrhosis in 2009, and calculate 
the change in incidence between 1998 and 2009. 
Results: 5118 incident cases of cirrhosis were identified, 57.9% were male. Over the 12-
year period crude incidence increased by 50.6%. Incidence increased for both men and 
women and all aetiology types. We estimated approximately 17000 people were newly 
diagnosed with cirrhosis in 2009 in the UK, greater than that of the fifth most common cancer 
non-hodgkin’s lymphoma. The percentage change in incidence of cirrhosis between 1998 
and 2009 for both men (45.2%) and women (28.4%) was greater than that seen for the top 
four most commonly diagnosed cancers in the UK (breast, lung, bowel and prostate).  
Conclusion: The occurrence of cirrhosis increased more than that of the top four cancers 
during 1998 to 2009 in England. Strategies to monitor and reduce the incidence of this 
disease are urgently needed. 
Keywords: Cirrhosis; Cancer; Epidemiology 
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INTRODUCTION 
In her most recent report the Chief Medical Officer of the UK has highlighted liver disease as 
the only major cause of mortality and morbidity that is rising in England [1]. However, in 
contrast to other chronic diseases with similar spectra of aetiology and survival such as 
cancer, where national registries have been collecting data for over 80 years [2], the UK 
currently has no registry to monitor the occurrence of newly diagnosed cases of cirrhosis. 
The assessment of the healthcare burden of liver disease remains reliant on mortality 
statistics [3,4]. The use of mortality data to monitor trends in incidence of liver disease, and 
in particular cirrhosis, is inadequate as these figures do not reflect the present day burden of 
a disease, as not all patients with cirrhosis will die as a direct result of their liver disease, 
particularly those with compensated disease.  
Previous population-based studies looking at cirrhosis, have used either primary or 
secondary care records in isolation to estimate the occurrence of cirrhosis in the UK [5,6,7].  
Our previous work is an example of a study where primary care data alone were used as 
hospital registry data, at the time of the study, were unavailable. Limiting data to just one 
source inevitably results in a selected population of either principally ambulatory people or 
patients with decompensated disease and consequently under- or over-estimates the 
occurrence of disease. Now, for the first time, through the relatively recent linkage of primary 
and secondary care data in England, we have established a comprehensive population-
based cohort that is representative of the whole population of people with cirrhosis from 
which incidence rates can be estimated more precisely than before.  
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Cirrhosis, like cancer, is preventable, can be detected early and has a high mortality rate. If 
trends in disease can be adequately monitored, as in the case of cancer, patients can be 
diagnosed earlier and provided with appropriate treatments and/or interventions to improve 
modifiable lifestyle factors. By comparing the occurrence of cirrhosis systematically with that 
of the top twenty diagnosed cancers in the UK our study puts a context to the burden of 
cirrhosis. 
The aim of this study is to establish a comprehensive and well-validated study population of 
patients with cirrhosis to determine precise estimates of the incidence in England, the rate of 
change in incidence and to directly compare these figures with those for the twenty most 
commonly diagnosed cancers in the UK.  
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METHODS  
Study design 
We used population-based routinely collected electronic healthcare data from primary and 
secondary care registries in England to identify incident cases of cirrhosis.   
Primary care data  
The Clinical Practice Research Datalink (CPRD) is a longitudinal electronic database 
consisting of anonymised primary care records of over 10 million patients in the UK, 
collected since 1987. The data are coded using the Read code system [8].  Participating 
practices are assigned an up to standard (UTS) date on completion of regular audits 
confirming data quality and completeness; patient-level data are also assessed [9]. The 
CPRD has previously been shown to be representative of the population of the UK [10]. 
Secondary care data  
The Hospital Episodes Statistics (HES) database comprises statutory records of all 
admissions (excluding outpatients) conducted in NHS hospitals and independent treatment 
centres in England, since 1989. For each period of time under the care of a consultant, a 
patient is assigned a primary diagnosis and up to 19 secondary diagnoses, coded using the 
ICD10 (International Classification of Diseases, tenth revision), and/or up to 24 recorded 
procedures coded using the OPCS4 (Office of Population, Censuses and Surveys’ 
classification of surgical operations and procedures, fourth revision). We accessed data for 
patients registered at CPRD practices in England that have given consent to be linked to the 
HES database. 
Death registry data  
The Office for National Statistics (ONS) provides death registry data for CPRD practices that 
are linked to the HES.  
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Study population 
We had access to data from all 244 CPRD practices in England linked to HES between April 
1997 and August 2010 and to the ONS between April 1998 and December 2010.  We 
defined cirrhosis in primary care if a person had a record containing a Read code for 
cirrhosis, oesophageal varices and/or portal hypertension in the CPRD. The Read code lists 
were adapted and updated from our previous externally validated definition [5]. We 
developed code lists for cirrhosis diagnosis in secondary case from ICD10 (K70.3, K71.7, 
K72.1, K74.4, K74.5, K74.6, K76.6, I85.0, I85.9, I86.4, I98.2) and OPCS4 (J06.1, J06.2, 
T46.1, T46.2, G10.4, G10.8, G10.9, G14.4, G17.4, G43.7). 
Incident observation period 
The incident observation period commenced on the latest of (i) 1st January 1998, (ii) one 
year after the patient’s current registration date or (iii) the practice’s UTS date. The one year 
cut-off was used to avoid including potential prevalent cases, adapted from Lewis et al.’s 
methodology [11]. The period terminated on the earliest of (i) date of death, (ii) date the 
patient left the practice, (iii) the practice’s last data collection date or (iv) 31st December 
2009.  
Validation of case definition 
For people with a cirrhosis diagnosis recorded in primary care we established how many had 
a subsequent hospital admission related to liver disease (e.g. alcoholic liver disease or 
chronic hepatitis). 
For patients identified with cirrhosis from secondary care records only, we searched in both 
their primary and secondary care records and ONS death registry data for codes related to 
liver disease. We also examined primary care free text data for any of the following terms: 
‘cirrhosis’, ‘ascites’, ‘varices’, ‘liver’, ‘portal hypertension’, ‘hepatic’, ‘jaundice’, or 
‘paracentesis’. 
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Diagnosis date 
For each patient we assigned the date of diagnosis as the first date associated with a Read 
or ICD10/OPCS4 code for cirrhosis within the observation period. Patients younger than 18 
years at diagnosis were excluded. 
Aetiology 
We searched the patient’s medical records for evidence of viral hepatitis, autoimmune and 
metabolic diseases We defined patients as having an underlying alcoholic aetiology if there 
was any mention in their primary or secondary care records of alcoholism, alcohol abuse, 
addiction or dependence, ‘problem drinking’ or referral to alcohol cessation services, or if 
their weekly alcohol consumption in their primary care records exceeded the Chief Medical 
Officer’s recommended amount (14 units for women, 21 units for men) [12]. Our Read code 
list for this was adapted from previous work [5] and our ICD10 code list was adapted from 
the codes used by Statistics on Alcohol, England [13]. Aetiology was ascribed in an 
hierarchical fashion of viral hepatitis, autoimmune or metabolic disease and alcoholic 
cirrhosis.  All remaining patients with no recorded aetiology were defined as cryptogenic 
cirrhosis. 
Statistical analysis 
We excluded patients whose date of diagnosis was concurrent with death. We used t-tests 
and difference in proportions for continuous and categorical variables respectively. We 
calculated crude incidence by dividing the number of cases by the total number of person-
years from the HES-linked CPRD population at risk during the incident observation period. 
For each valid year we calculated the proportion of person-years at risk excluding the first 
year post-registration. We looked at incidence by age, sex, aetiology and year of diagnosis.  
We fitted a Poisson model to determine adjusted incidence rate ratios (IRR). We calculated 
two separate point estimates of prevalence using all cases who were contributing data to 
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HES-linked CPRD at 1 July 1999 and 1 July 2009. The total HES-linked CPRD population 
aged 18 years or older at each time point was used as the denominator. Stata version 
12/MP4 was used for all statistical analyses. 
Comparison with cancer 
To make a comparison with the incidence of cancer we obtained the number of new cases 
diagnosed in 2009 for the top twenty most diagnosed cancers from Cancer Research UK 
[14]. To determine the percentage change in incidence over time, for each cancer, Cancer 
Research UK applied their age-specific incidence figures to the age-standardised European 
population and determined age-standardised rates per 100,000 person-years for men and 
women. From this they calculated the percentage change between the period 1998-2000 to 
2007-2009. We applied the same methodology to our cirrhosis incidence figures to estimate 
the number of new cases diagnosed in 2009 in the UK and the percentage change in 
incidence for European age-standardised rates for men and women over the same period. 
We added our cirrhosis figures to graphs provided by Cancer Research UK.  
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RESULTS 
Study cohort 
Combining 2282 patients identified in secondary care with 2965 patients who had a 
diagnosis in primary care, and excluding 129 (2.5%) patients whose date of diagnosis was 
concurrent with death, we established an incident study cohort of 5118 people diagnosed 
with cirrhosis during the observation period.  
Patient characteristics 
In the cohort of 5118 patients, with a mean age of 59.3 (sd=14.3) years, there were slightly 
more men (57.9%) than women, and just over half of the population had alcoholic cirrhosis 
(53.9%). Median follow-up was 1.97 [inter-quartile range: 0.42, 4.39] years. The following 
patients had a non-alcohol aetiology: 574 (11.2%) chronic viral hepatitis, 362 (7.1%)  
autoimmune disease, 143 (2.8%) metabolic disease and 1283 (25.1%) cryptogenic cirrhosis.  
Numbers in the autoimmune and metabolic disease categories were small so have been 
combined for all subsequent analyses.  
Incidence 
Over the 12-year period crude incidence was 30.7 cases per 100,000 person years, 
increasing from 25.8 in 1998 to 37.5 per 100,000 person years in 2009 (Table 1). This 
increase fitted a continuous model with an average yearly incidence rate ratio of 1.04 (95% 
CI [1.03 to 1.05]) adjusted for age and sex, corresponding to a 50.6% increase over the time 
studied. Incidence was about 50% higher in men than women, 36.2 cases per 100,000 
person-years and 25.4 cases per 100,000 person-years, respectively, IRR 1.50 (95% CI 
[1.42 to1.58]) adjusted for age and year of diagnosis) (Figure 1). Adjusted incidence rate 
ratios are shown in Table 1.  
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Aetiology 
A higher proportion of men than women had alcoholic cirrhosis, 61.9% vs.42.8% respectively 
(P<0.001) and the distribution of aetiology varied by age (P<0.001). For men, a larger 
proportion of the younger patients had alcoholic cirrhosis. For women twice as many had 
cryptogenic cirrhosis, compared to men, in the younger age-groups and approximately four 
times as many had cryptogenic compared to alcoholic cirrhosis in those older than 75 years 
(Table 2). 
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Between 1998 and 2009, adjusting for age, statistically significant increases in the incidence 
of both alcoholic and non-alcoholic cirrhosis were seen in men, 32.8% (95% CI [4.0% to 
69.5%]) and 72.1% (95% CI [24.8% to 137%]) respectively. In women, a 25.9% (95% CI [-
12.1% to 80.5%]) increase was seen in those with alcoholic cirrhosis and a statistically 
significant 43.6% increase (95% CI [5.2% to 95.9%]) in those with non-alcohol related 
cirrhosis. Figures 2 and 3 show the trends over time for each type of aetiology, for men and 
women respectively. There was a consistently higher proportion of men with alcoholic-
cirrhosis than with non-alcohol related aetiology. The converse was true for women. In cases 
with cryptogenic cirrhosis, in particular, there was a 1.7 fold (IRR 1.69 95% CI [1.10, 2.60]) 
increase in incidence in men and a 2.5 fold (IRR 2.52 95% CI [1.57 to 4.05]) increase in 
incidence in women, adjusted for age.  
 
Prevalence 
Using all cases contributing to the HES-linked CPRD at two separate time points we saw an 
increase in the prevalence of cirrhosis between 1 July 1999 and 1 July 2009 from 24.7 to 
179 per 100,000 population aged 18 years or above representing over a seven-fold increase 
in the prevalence of this disease over this ten year period. 
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Comparison with cancer 
We estimated that 10478 and 6808 cirrhosis cases were newly diagnosed in men and 
women respectively in the UK in 2009. Figure 4 shows that our estimated number of 
cirrhosis cases was greater than that of the fifth most common cancer, non-hodgkin’s 
lymphoma, for both men and women. There was a 45.2% increase in European age-
standardised incidence rates of cirrhosis incidence in males comparing the period 1998-
2000 to 2007-2009.  For women the percentage increase was 28.4%. Supplementary 
Figures 1 and 2 show how these percentage changes compare to the twenty most 
commonly diagnosed cancers in the UK for the same period. The increase in incident 
cirrhosis was greater than all cancers apart from malignant melanoma, thyroid, kidney and 
liver (the latter three for women only).  
 
Validation of case definition 
Of the 2975 people identified as incident cirrhosis cases in primary care records during the 
study period 2230 (75%) had a hospital admission related to liver disease. Ten patients had 
a cirrhosis code in secondary care in 1997 so were excluded. 
Of the 2282 patients who had a cirrhosis diagnosis in secondary care only during the study 
period, and no cirrhosis diagnostic Read code in primary care, 2062 (90.3%) had either 
death or additional evidence related to liver disease in their records, or a confirmation of a 
cirrhosis diagnosis in their free text. 
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DISCUSSION 
We found a 50.6% increase in incidence of cirrhosis in England between 1998 and 2009. 
Over this period cirrhosis occurred more commonly and at younger ages in men than 
women.  A significant increase in both alcoholic and non-alcoholic related cirrhosis was seen 
for men across the period under study. In women there was a significant increase for non-
alcoholic cirrhosis only, specifically in cryptogenic cirrhosis. We estimate that, over the age 
of 18, approximately 17000 people were newly diagnosed with cirrhosis in 2009 in the UK.  
In comparison with the top twenty most diagnosed cancers in the UK, the estimated burden 
(new diagnoses) of cirrhosis was greater than all bar the big four cancers of breast, lung, 
bowel and prostate. In addition, the percentage change in European age-standardised 
incidence rates of cirrhosis from 1998 to 2009 was higher than that seen in all of these top 
four cancers and lower only than the percentage change in malignant melanoma, (and 
thyroid, liver and kidney in women only).   
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Strengths and limitations 
This is the first population-based study using linked primary and secondary healthcare data 
to establish a comprehensive cohort to measure the occurrence of cirrhosis in England. 
Given that using one data source alone does not capture all incident cases of cirrhosis, we 
are confident that our estimates of incidence are more accurate than has been determined 
previously, including those provided in own previous work [5]. To be able to widely 
generalise our findings we need to be confident that the population we have studied is truly 
representative of all patients with cirrhosis.  Given that the data we have used is broadly 
similar in terms of demographics to that of England we believe we have a representative 
population [10]. 
Our definition of cirrhosis in secondary care, compared to that used by other studies, which 
included codes for chronic hepatitis and alcoholic liver disease [4,15], ensures that we are 
only including patients who have good evidence of cirrhosis.  While we have assigned a 
diagnosis date as the incident date of disease in our study (so as to be able to calculate 
rates of occurrence from a defined denominator) we appreciate that given the long sojourn 
time for cirrhosis to develop this will not be the onset of disease. However this is analogous 
to the situation for most cancers meaning that our comparisons of incidence are on the same 
footing.  
There are often questions raised about the validity of coding seen in both primary and 
secondary care data [16,17,18] but in most studies that have validated recording of chronic 
disease accuracy has been high [19,20]. A limitation of the HES data is that they cannot be 
directly validated against medical records due to the anonymisation process used. But a 
recent government audit found 91% median accuracy in clinical coding of diagnoses and 
procedures [21]. The linked data in our study have improved our case definitions by 
providing supporting evidence of liver disease among the various healthcare records.   
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Finally, we identified a record of alcohol use consistent with it being the underlying aetiology 
of disease in just over 50% of the patients. This is almost identical to that found by Saunders 
et al. (52%) between 1959 and 1976 and that of Fleming et al. (50.3%) based on primary 
care records only [5,7]. It is therefore highly likely that we have underestimated alcohol 
consumption, possibly reflecting poor recording of alcohol intake.  
 
Other studies 
A summary of the findings of selected, large, population-based previous studies are 
presented in Table 3.  While not exhaustive this table allows us to provide a context for our 
results in comparison to studies that are broadly similar in scope and nature to ours. Our 
study is best compared to the two largest previous studies estimating incidence of liver 
cirrhosis in the UK [5,7]. The study by Saunders et al. identified one tenth the size of our 
study population in the West Midlands using hospital and death registry data and reported 
an increase in incidence from 5.6 to 15.3 per 100,000 person-years during the period 1959-
1976. Our group’s previous study that used solely primary care data found a 48% increase in 
incidence from 1992 to 2002, from 12 to 17 per 100,000 person years. Our overall estimate 
of incidence of 30 per 100,000 person years is higher than both these studies which is 
unsurprising given that Saunders et al.’s study was carried out more than fifty years ago and 
the study by Fleming et al. most probably underestimated the burden of disease due to not 
having access to linked secondary care data.  However, the rate of change we describe is 
almost identical to that of the latter study.  
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In comparison to some studies conducted in Denmark, one used both in- and out-patients 
during 1996-2006 and therefore had a comprehensive cohort similar to ours [25]. Their 
overall incidence findings were similar to ours however the authors did not look at trends 
over time nor make a comparison between the different types of aetiology. In contrast to our 
findings, the other Danish study found no discernable trend in incidence of alcoholic cirrhosis 
during the study period, 1995-2006 [23]. Even though there has been an increase in alcohol 
consumption in the UK over the last twenty years [26], our study also shows that there has 
been a concurrent rise in the number of people with non-alcohol cirrhosis. In particular we 
have reported a substantial increase in those with cryptogenic cirrhosis. Many cases of 
cryptogenic cirrhosis are likely to be end stage non-alcoholic steatohepatitis encompassed 
within the spectrum of non-alcohol fatty liver disease (NAFLD) [27]. Obesity is linked to 
NAFLD [28], and the increase in the incidence of cryptogenic cirrhosis we report may reflect 
the increase in obesity seen in the UK over the last few decades [29]. 
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Comparison with cancer 
In England more than one in three people will develop cancer at some stage in their lives 
[30]. In the year 2000 the British government established a NHS plan for cancer: a 
comprehensive strategy for bringing together prevention, screening, diagnosis, treatment 
and care [30]. National registries have been set up in England over the last 80 years to 
monitor trends of incidence [2]. In contrast, no services for monitoring and detecting cirrhosis 
have been provided despite the fact that in 2001 the CMO reported a dramatic increase in 
the occurrence of liver disease in the UK [31]. Our use of population-based, routinely 
available, linked electronic health records has allowed us to show that the incidence of 
cirrhosis has increased more than that of the top four cancers during the period 1998 to 
2009 in England. According to Cancer Research UK’s predictions overall cancer death rates 
are expected to fall by 17% by 2030 in the UK [32]. Stark contrast to that predicted for 
alcohol related liver deaths and implied both by our incidence figures and by the rising 
mortality rates recently reported [3,33]. We have demonstrated how electronic routine 
healthcare databases could fill the gap that currently exists given that the UK has no registry 
to monitor the occurrence of cirrhosis which is escalating at an alarming rate. In addition to 
filling this gap, using electronic routine databases will help answer other research questions 
such as the regional variation of the disease and implications on cost and optimisation of 
healthcare resource allocation. 
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Conclusion 
Cirrhosis represents a serious and growing burden of morbidity and mortality across 
England, for all aetiologies and for both men and women. Our study is the first to establish a 
comprehensive, representative sample of people with cirrhosis using population-based data 
analogous to cancer registries in England therefore allowing a direct comparison to be made 
with the incidence of cancer. The aetiology of cirrhosis encompasses many preventable 
exposures such as chronic viral hepatitis, alcohol consumption and the causes of obesity 
therefore it is crucial to be able to count the number of newly occurring diagnoses of this 
disease over time in a reproducible manner. This will allow one to assess the impact of both 
individual and population level intervention on the occurrence of this disease. Given the 
continued rise in cirrhosis which we have described, greater than that seen for almost all of 
the most commonly diagnosed cancers in the UK it is imperative that strategies are put in 
place to monitor the trends in this disease more closely.   
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Figure Legends 
 
 
Figure 1: Incidence of cirrhosis (per 100,000 person-years) by year and sex, England, 1998-
2009 
Figure 2: Incidence of cirrhosis (per 100,000 person-years) by aetiology, males 1998-2009 
(colour) 
Figure 3: Incidence of cirrhosis (per 100,000 person-years) by aetiology, females 1998-2009 
(colour) 
Figure 4: The number of cases for the 20 most common cancers in the UK and cirrhosis of 
the liver, in 2009. Adapted from Cancer Research UK [14]. 
 
Supplementary Figure Legends 
Supplementary Figure 1: Percentage change in European age-standardised rates per 
100,000 person-years for cirrhosis of the liver and the most common cancers in the UK, 
females, 1998-2000 to 2007-2009. Adapted from Cancer Research UK [14]. 
Supplementary Figure 2: Percentage change in European age-standardised rates per 
100,000 person-years for cirrhosis of the liver and the most common cancers in the UK, 
males, 1998-2000 to 2007-2009. Adapted from Cancer Research UK [14].
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Table 1: Incidence of cirrhosis, 1998-2009 
Total Cases 
 
 
 
 
5118 
P-yrs 
 
 
 
 
16,672753 
Crude Incidence rates 
[95% CI] per 100,000 
pyrs 
 
 
30.70 (29.87 to 31.55) 
Adjusted incidence 
rate ratios [95% CI]¥ 
Sex     
Female 2153 8,490,621 25.36 (24.31 to 26.45) 1 
Male 2965 8,182,132 36.24 (34.96 to 37.57) 1.50 (1.42 to 1.58) 
     
Age (years)     
18-34 189 4124431 4.58 (3.97 to 5.28) 1 
35-44 561 3271016 17.15 (15.79 to 18.63) 3.75 (3.18 to 4.42) 
45-54 1149 2974413 38.63 (36.46 to 40.93) 8.45 (7.24 to 9.85) 
55-64 1302 2613275 49.82 (47.19 to 52.60) 10.85 (9.32 to 12.64) 
65-74 1020 1889873 53.97 (50.76 to 57.39) 11.93 (10.22 to 13.94) 
75-84 714 1299395 54.95 (51.06 to 59.13) 12.49 (10.64 to 14.66) 
85+ 183 500350 36.57 (31.64 to 42.28) 8.67 (7.07 to 10.62) 
     
Aetiology*     
Alcohol 2756 16,672753 16.53 (15.92 to 17.16)  
Viral hepatitis 574 16,672753 3.44 (3.17 to 3.74)  
Autoimmune/Metabolic  
diseases 
505 16,672753 3.03 (2.78 to 3.30)  
Cryptogenic 1283 16,672753 7.70 (7.29 to 8.13)  
     
Year of diagnosis     
1998 239 925730 25.82(22.74 to 29.31) 1 
1999 262 1071075 24.46 (21.67 to 27.61) 0.95 (0.80 to 1.13) 
2000 340 1252827 27.14 (24.40 to 30.18) 1.05 (0.89 to 1.24) 
2001 350 1351657 25.89 (23.32 to 28.75) 1.00 (0.85 to 1.17) 
2002 398 1401538 28.40 (25.74 to 31.33) 1.09 (0.93 to 1.28) 
2003 409 1430505 28.59 (25.95 to 31.50) 1.09 (0.93 to 1.28) 
2004 453 1458347 31.06 (28.33 to 34.06) 1.18 (1.01 to 1.38) 
2005 453 1481626 30.57 (27.88 to 33.52) 1.16 (0.99 to 1.36) 
2006 486 1521211 31.95 (29.23 to 34.96) 1.22 (1.04 to 1.42) 
2007 526 1561949 33.68 (30.92 to 36.68) 1.28 (1.10 to 1.49) 
2008 594 1594729 37.25 (34.37 to 40.37) 1.42 (1.22 to 1.65) 
2009 608 1621559 37.49 (34.63 to 40.60) 1.42 (1.23 to 1.65) 
Pyrs=person-years; CI=confidence intervals; *Adjusted IRRs cannot be calculated as denominator 
data cannot be categorised by aetiology and compared with one another; ¥ Adjusted for age, sex or 
year of diagnosis. 
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Table 2: The distribution of aetiology by age-group and by sex: row %s (95%CI) 
Aetiology n Cryptogenic Alcoholic  Viral hepatitis  Autoimmune/Metabolic 
diseases 
MEN      
Age (years) 
18-34 
 
105 
 
21 (13.1 to 28.8) 
 
54.3 (44.7 to 63.9) 
 
17.1 (9.9 to 24.4) 
 
7.6 (2.5 to 12.7) 
35-44 341 8.5 (5.5 to 11.5) 65.1 (60 to 70.2) 21.7 (17.3 to 26.1) 4.7 (2.4 to 6.9) 
45-54 702 8.7 (6.6 to 10.8) 70.4 (67 to 73.8) 16.4 (13.6 to 19.1) 4.6 (3.0 to 6.1) 
55-64 790 13.9 (11.5 to 16.3) 70.0 (66.8 to 73.2) 9.4 (7.3 to 11.4) 6.7 (5.0 to 8.5) 
65-74 580 28.6 (24.9 to 32.3) 58.3 (54.3 to 62.3) 5.7 (3.8 to 7.6) 7.4 (5.3 to 9.5) 
75-84 369 46.9 (41.8 to 52) 40.7 (35.6 to 45.7) 4.6 (2.5 to 6.7) 7.9 (5.1 to 10.6) 
85+ 78 66.7 (56.1 to 77.2) 25.6 (15.9 to 35.4) 5.1 (0.2 to 10.1) 2.6 (-1.0 to 60.9) 
Overall 2965 20.7 (19.2 to 22.1) 61.9(60.1 to 63.3) 11.3(10.2 to 12.4) 6.2 (5.3 to 7) 
WOMEN      
Age (years) 
18-34 
 
84 
 
42.9 (32.2 to 53.5) 
 
35.7 (25.4 to 46) 
 
15.5 (7.7 to 23.3) 
 
6.0 (0.9 to 11) 
35-44 220 20.0 (14.7 to 25.3) 56.4 (49.8 to 62.9) 15.9 (11.1 to 20.8) 7.7 (4.2 to 11.3) 
45-54 447 13.7 (10.5 to 16.8) 63.5 (59.1 to 68) 13.2 (10.1 to 16.3) 9.6 (6.9 to 12.4) 
55-64 512 21.3 (17.7 to 24.8) 53.5 (49.2 to 57.8) 9.6 (7 to 12.1) 15.6 (12.5 to 18.8) 
65-74 440 35.7 (31.2 to 40.2) 31.8 (27.5 to 36.2) 10.7 (7.8 to 13.6) 21.8 (18 to 25.7) 
75-84 345 55.4 (50.1 to 60.6) 17.1 (13.1 to 21.1) 8.4 (5.5 to 11.3) 19.1 (15 to 23.3) 
85+ 105 68.6 (59.6 to 77.5) 10.5 (4.6 to 16.4) 6.7 (1.9 to 11.5) 14.3 (7.6 to 21) 
Overall 2153 31.1(29.2 to33.1) 42.8(40.7 to 44.9) 11.1(9.8 to 12.4) 15(13.4 to 16.5) 
 CI=confidence intervals 
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Table 3: Summary of selected studies of the incidence of cirrhosis of the liver 
 
Author/Year Study 
location 
Time period Data source & 
population 
Cohort 
size 
Definition of 
cirrhosis diagnosis 
Demographics Incidence 
Saunders et al. 
19817 
W. 
Midlands 
UK 
 
1959 - 1976 Hospital 
registry 
Pathology 
registry 
Age 15 years + 
512 Medical notes: 
evidence from liver 
biopsy, post-
mortem or clinical 
biochemical results. 
Pathology : autopsy 
files, death 
certificates 
Does not present % of 
men.  
 
Mean age for men 
alcohol cirrhosis was 53 
years, for women 55.2 
years. 
 
Alcohol cirrhosis was 
50.6%. 
5.6 per 100,000 in 1959 
15.3 per 100,000 in 1974 
Ludviksdottir 
et al. 1996
22
 
Iceland 1971-1990 
Age 20 years 
+ 
Death registry 
Hospital 
registry 
Biopsy/autopsy 
records 
 
142 Histological 
evidence (liver 
biopsy) 
Men 45% 
Alcohol cirrhosis 44% 
22.1 per 1,000,000 pyrs for AC 
25.9 per 1,000,000 pyrs for 
NAC 
Roberts et al. 
2005
6
 
 
Oxford 
UK 
1968 - 1999 Hospital 
registry 
Age 15 years + 
8192 ICD9: Alcohol 
Cirrhosis  
( 571.0, 571.1, 
571.2, 571.3); Non-
Alcohol Cirrhosis 
(571.4, 
571.5,571.8,571.9) 
ICD10: K70, K73, 
K74, K76.0 
Men 55% 
Mean age 57.5 
 
Not reported 
Leon et al. 
20064 
Britain 1950-2002 WHO mortality 
database 
 ICD7: 581 
ICD8/9: 571 
ICD10: K70, K73, 
K74 
 
No age provided or % 
men 
Not reported 
Jepsen et al. 
200823 
Denmark 1995-2006 National 
Hospital 
registry 
Death registry 
 
14,976 ICD8: 571.09, 
571.92, 571.99 
ICD10: K70.3, K74.6 
Men 66.4% 
Alcohol cirrhosis 68.7% 
Not reported 
Gunnarsdottir 
et al. 
200924 
 
Iceland & 
Sweden 
(Got’berg)  
1994-2003 Hospital & 
outpatient 
registry. No 
age criteria 
specified. 
1016 Diagnosis database 
used to identify 
patients first.  
Clinical criteria used 
to confirm cirrhosis 
and define 
mortality.  
Sweden n=918, alcohol 
62%, men 69.3% 
Iceland n=98, alcohol 
32%, men 52% 
Gothenburg: 
15.3 per 100,000 pyrs p.a 
Iceland: 
3.3 per 100,000 pyrs p.a 
 
Lui et al 201015 UK Recruitment 
from 1996 to 
2001. F/up 
to 2003 in 
England, 
2005 in 
Scotland 
Hospital 
registry  
1811 ICD10: K70, K73, 
K74 
Mean age at recruitment 
56 
 
1.2 per 1000 women over five 
years 
Fleming et al. 
20115 
UK 1992 - 2001 Primary care 
records 
Age 25 + years 
3360 Read codes for 
cirrhosis, portal 
hypertension and 
oesophageal varices 
Men 58%  
Median age 56.3 (men) 
61.3 (women) 
Alcohol cirrhosis 38.3% 
14.5 per 100,000 pyrs 
Fialla et al.
25
 
2012 
Funen, 
Denmark 
1996 - 2006 Hospital & 
outpatient 
registry 
1369 Initially 35 ICD10 
codes including: 
K70, K73, K74, K830, 
B18, K717, K718, 
K738, K739, K758, 
K759,  K761, K721, 
K729, K767, E831, 
E88, I850, I859, 
I864, R189, C220, 
Z944 and then 
clinical criteria: liver 
biopsy or post-
mortem autopsy, 
portal hypertension, 
prolonged bleeding 
time, irregular liver 
surface, evidence of 
complications. 
Men 67%  
Alcohol  cirrhosis 79%  
 
33 per 100,000 pyrs 
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AC=alcoholic cirrhosis; NAC=non-alcoholic cirrhosis; pyrs=person-years; F/up=follow-up. ICD=International 
Classification of Diseases 
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